Insider Transactions in Q1 2025 at Sana Biotechnology, Inc. (SANA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2025
|
Steve Harr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,820
-0.16%
|
$25,640
$2.56 P/Share
|
|
Mar 10
2025
|
Bernard J Cassidy EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,833
-2.45%
|
$5,666
$2.56 P/Share
|
|
Mar 10
2025
|
Susan D. Wyrick |
SELL
Payment of exercise price or tax liability
|
Direct |
836
-0.53%
|
$1,672
$2.56 P/Share
|
|
Mar 07
2025
|
Steve Harr President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+0.63%
|
-
|
|
Mar 07
2025
|
Bernard J Cassidy EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
11,041
+8.7%
|
-
|
|
Mar 07
2025
|
Susan D. Wyrick |
BUY
Exercise of conversion of derivative security
|
Direct |
3,250
+2.01%
|
-
|
|
Mar 03
2025
|
Susan D. Wyrick |
SELL
Payment of exercise price or tax liability
|
Direct |
490
-0.32%
|
$980
$2.56 P/Share
|
|
Mar 02
2025
|
Susan D. Wyrick |
BUY
Exercise of conversion of derivative security
|
Direct |
1,525
+0.97%
|
-
|
|
Jan 08
2025
|
Fmr LLC |
SELL
Open market or private sale
|
Indirect |
290,912
-1.53%
|
$1,745,472
$6.65 P/Share
|
|
Jan 06
2025
|
Hans Edgar Bishop |
BUY
Grant, award, or other acquisition
|
Direct |
14,285
+0.25%
|
-
|
|
Jan 02
2025
|
Susan D. Wyrick |
SELL
Payment of exercise price or tax liability
|
Direct |
1,566
-1.01%
|
$1,566
$1.65 P/Share
|
|
Jan 02
2025
|
Susan D. Wyrick |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+3.12%
|
-
|